The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Open accessAbstract
Cancer cells survive cellular crisis through telomere maintenance mechanisms. We report telomere lengths in 18,430 samples, including tumors and non-neoplastic samples, across 31 cancer types. Telomeres were shorter in tumors than in normal tissues and longer in sarcomas and gliomas than in other cancers. Among 6,835 cancers, 73% expressed telomerase reverse transcriptase (TERT), which was associated with TERT point mutations, rearrangements, DNA amplifications and transcript fusions and predictive of telomerase activity. TERT promoter methylation provided an additional deregulatory TERT expression mechanism. Five percent of cases, characterized by undetectable TERT expression and alterations in ATRX or DAXX, demonstrated elongated telomeres and increased telomeric repeat-containing RNA (TERRA). The remaining 22% of tumors neither expressed TERT nor harbored alterations in ATRX or DAXX. In this group, telomere length positively correlated with TP53 and RB1 mutations. Our analysis integrates TERT abnormalities, telomerase activity and genomic alterations with telomere length in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various mechanisms have been identified to alter hTERT gene expression, including methylation of its promoter, mutational changes within the promoter, amplifications, and structural variations [193].”
From Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy (2024) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Aligning sequence reads, clone sequences and assembly con*gs with BWA-MEMPreprint
Li, H. (2014) · arXiv (Cornell University) · doi:10.6084/m9.figshare.963153.v1 · Cited by 5,155
Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,520
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
Davies, L., & Welch, H. G. (2006) · JAMA · doi:10.1001/jama.295.18.2164 · Cited by 3,379
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Cited by
Sorted by citations
Pan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
Self-citationGenome doubling shapes the evolution and prognosis of advanced cancers
Bielski, C. M., Zehir, A., Penson, A. V., Donoghue, M. T. A., Chatila, W. K., Armenia, J., Chang, M. T., Schram, A. M., Jonsson, P., Bandlamudi, C., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0165-1 · Cited by 654
Determinants of telomere length across human tissues
Demanelis, K., Jasmine, F., Chen, L. S., Chernoff, M., Tong, L., Delgado, D., Zhang, C., Shinkle, J., Sabarinathan, M., Lin, H., et al. (2020) · Science · doi:10.1126/science.aaz6876 · Cited by 515
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Mitchell, T. J., Turajlic, S., Rowan, A., Nicol, D. L., Farmery, J. H. R., O’Brien, T., Martincorena, I., Tarpey, P. S., Angelopoulos, N., Yates, L. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.020 · Cited by 522
Yuan, X., Larsson, C., & Xu, D. (2019) · Oncogene · doi:10.1038/s41388-019-0872-9 · Cited by 450
Telomere Biology and Human Phenotype
Turner, K. J., Vasu, V., & Griffin, D. K. (2019) · Cells · doi:10.3390/cells8010073 · Cited by 415
Polygenic basis and biomedical consequences of telomere length variation
Codd, V., Wang, Q., Allara, E., Musicha, C., Kaptoge, S. K., Stoma, S., Jiang, T., Hamby, S. E., Braund, P. S., Bountziouka, V., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00944-6 · Cited by 381
Self-citationBao, H., Cao, J., Chen, M., Min, C., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., Chen, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 402
Self-citationRegulation of human telomerase in homeostasis and disease
Roake, C. M., & Artandi, S. E. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0234-z · Cited by 356
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
Newell, F., Kong, Y., Wilmott, J. S., Johansson, P. A., Ferguson, P. M., Cui, C., Li, Z., Kazakoff, S. H., Burke, H., Dodds, T. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11107-x · Cited by 340
Risk factors for childhood and adult primary brain tumors
Ostrom, Q. T., Fahmideh, M. A., Cote, D. J., Muskens, I. S., Schraw, J. M., Scheurer, M. E., & Bondy, M. L. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz123 · Cited by 314
TERT—Regulation and Roles in Cancer Formation
Dratwa, M., Wysoczańska, B., Łacina, P., Kubik, T., & Bogunia‐Kubik, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.589929 · Cited by 331
Telomeres and Telomere Length: A General Overview
Srinivas, N., Rachakonda, P. S., & Kumar, R. (2020) · Cancers · doi:10.3390/cancers12030558 · Cited by 336
Integrative genomic and transcriptomic analysis of leiomyosarcoma
Chudasama, P., Mughal, S. S., Sanders, M. A., Hübschmann, D., Chung, I., Deeg, K. I., Wong, S.-H., Rabe, S., Hlevnjak, M., Zapatka, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02602-0 · Cited by 316
TERRA RNA Antagonizes ATRX and Protects Telomeres
Chu, H.-P. C., Cifuentes‐Rojas, C., Kesner, B., Aeby, E., Lee, H.-G., Wei, C., Oh, H. J., Boukhali, M., Haas, W., & Lee, J. T. (2017) · Cell · doi:10.1016/j.cell.2017.06.017 · Cited by 273
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Leao, R. R. N., Apolónio, J. D., Lee, D., Figueiredo, A., Tabori, U. Y., & Castelo‐Branco, P. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0422-8 · Cited by 273
Targeting telomerase for cancer therapy
Guterres, A. N., & Villanueva, J. (2020) · Oncogene · doi:10.1038/s41388-020-01405-w · Cited by 265
Genomic and evolutionary classification of lung cancer in never smokers
Zhang, T., Joubert, P., Ansari‐Pour, N., Wei, Z., Hoang, P. H., Lokanga, R. A., Moye, A. L., Rosenbaum, J., González-Pérez, A., Martínez-Jiménez, F., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00920-0 · Cited by 243
TumorFusions: an integrative resource for cancer-associated transcript fusions
Hu, X., Wang, Q., Tang, M., Barthel, F. P., Amin, S. B., Yoshihara, K., Lang, F., Martínez-Ledesma, E., Lee, S. H., Zheng, S., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1018 · Cited by 238
Self-citationThe role of telomeres and telomerase in cirrhosis and liver cancer
Nault, J., Ningarhari, M., Rebouissou, S., & Zucman‐Rossi, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0165-3 · Cited by 255
Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies
Gao, J., & Pickett, H. A. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00490-1 · Cited by 213
Epidemiology of Brain and Other CNS Tumors
Ostrom, Q. T., Francis, S. S., & Barnholtz‐Sloan, J. S. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01152-9 · Cited by 198
Min, J., Wright, W. E., & Shay, J. W. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00226-17 · Cited by 204
de Vitis, M., Berardinelli, F., & Sgura, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020606 · Cited by 182
Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks
Zhang, J., & Zou, L. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00391-6 · Cited by 192
Self-citationMenghi, F., Barthel, F. P., Yadav, V. K., Tang, M., Ji, B., Tang, Z., Carter, G. W., Ruan, Y., Scully, R., Verhaak, R. G. W., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.008 · Cited by 179
Self-citationSignaling pathways in hepatocellular carcinoma
García‐Lezana, T., Lopez-Canovas, J. L., & Villanueva, A. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.002 · Cited by 175
Fishbein, L. M., Rivero, J. D., Else, T., Howe, J. R., Asa, S. L., Cohen, D. L., Dahia, P. L. M., Fraker, D. L., Goodman, K. A., Hope, T. A., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001792 · Cited by 161
Revisiting Telomere Shortening in Cancer
Okamoto, K., & Seimiya, H. (2019) · Cells · doi:10.3390/cells8020107 · Cited by 161
Adrenocortical carcinoma — towards genomics guided clinical care
Crona, J., & Beuschlein, F. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0221-7 · Cited by 142
Job, S., Drašković, I., Burnichon, N., Buffet, A., Cros, J. F., Lépine, C., Vénisse, A., Robidel, E., Verkarre, V., Méatchi, T., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0139 · Cited by 141
Genomic footprints of activated telomere maintenance mechanisms in cancer
Sieverling, L., Hong, C., Koser, S. D., Ginsbach, P., Kleinheinz, K., Hutter, B., Braun, D. M., Cortés‐Ciriano, I., Xi, R., Kabbe, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13824-9 · Cited by 141
Self-citationTelomere Maintenance Mechanisms in Cancer
Gaspar, T. B., Sá, A., Lopes, J. M., Sobrinho-Simões, M. A., Soares, P., & Vinagre, J. (2018) · Genes · doi:10.3390/genes9050241 · Cited by 144
Li, F., Deng, Z., Zhang, L., Wu, C., Jin, Y., Hwang, I., Vladimirova, O. V., Xu, L., Yang, L., Lu, B., et al. (2019) · The EMBO Journal · doi:10.15252/embj.201796659 · Cited by 135
Self-citationIntratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
Juratli, T. A., Thiede, C., Koerner, M. V. A., Tummala, S. S., Daubner, D., Shankar, G. M., Williams, E. A., Martinez‐Lage, M., Soucek, S., Robel, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22650 · Cited by 125
Mirian, C., Duun‐Henriksen, A. K., Juratli, T. A., Sahm, F., Spiegl‐Kreinecker, S., Peyre, M., Biczok, A., Tonn, J., Goutagny, S., Bertero, L., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322257 · Cited by 126
TelomereHunter – in silico estimation of telomere content and composition from cancer genomes
Feuerbach, L., Sieverling, L., Deeg, K. I., Ginsbach, P., Hutter, B., Buchhalter, I., Northcott, P. A., Mughal, S. S., Chudasama, P., Glimm, H., et al. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2851-0 · Cited by 120
Telomeres and telomerase in oncogenesis (Review)
Trybek, T., Kowalik, A., Góźdź, S. S., & Kowalska, A. (2020) · Oncology Letters · doi:10.3892/ol.2020.11659 · Cited by 132
Ningarhari, M., Caruso, S., Hirsch, T. Z., Bayard, Q., Franconi, A., Védié, A., Noblet, B., Blanc, J., Amaddeo, G., Ganne‐Carrié, N., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.052 · Cited by 118
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
Hartlieb, S., Sieverling, L., Nadler-Holly, M., Ziehm, M., Toprak, U. H., Herrmann, C., Ishaque, N., Okonechnikov, K., Gartlgruber, M., Park, Y.-G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21247-8 · Cited by 115
Chen, L., Chen, C., Chen, W., Li, K., Chen, X., Tang, X.-D., Xie, G., Luo, X. Q., Wang, X., Liang, H., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b04807 · Cited by 111
Structural variations in cancer and the 3D genome
Dubois, F. P. B., Sidiropoulos, N., Weischenfeldt, J., & Beroukhim, R. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00488-9 · Cited by 112
Sahm, F., Brandner, S., Bertero, L., Capper, D., French, P. J., Figarella-Branger, D. F., Giangaspero, F., Haberler, C., Hegi, M. E., Kristensen, B. W., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad100 · Cited by 113
TERT Promoter Alterations in Glioblastoma: A Systematic Review
Olympios, N., Gilard, V., Marguet, F., Clatot, F., Fiore, F. D., & Fontanilles, M. (2021) · Cancers · doi:10.3390/cancers13051147 · Cited by 125
The translational challenges of precision oncology
Pich, O., Bailey, C., Watkins, T. B. K., Zaccaria, S., Jamal‐Hanjani, M., & Swanton, C. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.04.002 · Cited by 116
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Newell, F., Johansson, P. A., Wilmott, J. S., Nones, K., Lakis, V., Pritchard, A. L., Lo, S., Rawson, R. V., Kazakoff, S. H., Colebatch, A. J., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0603 · Cited by 119
The regulations of telomerase reverse transcriptase (TERT) in cancer
Liu, M., Zhang, Y., Jian, Y., Gu, L., Zhang, D., Zhou, H., Wang, Y., & Xu, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06454-7 · Cited by 119
Comparative Molecular Life History of Spontaneous Canine and Human Gliomas
Amin, S. B., Anderson, K. J., Boudreau, C. E., Martínez-Ledesma, E., Kocakavuk, E., Johnson, K. C., Barthel, F. P., Varn, F. S., Kassab, C., Ling, X., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.01.004 · Cited by 107
Self-citationTelomerase Regulation: A Role for Epigenetics
Doğan, F., & Forsyth, N. R. (2021) · Cancers · doi:10.3390/cancers13061213 · Cited by 107
TERT gene: its function and dysregulation in cancer
Colebatch, A. J., Dobrovic, A., & Cooper, W. A. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205653 · Cited by 104
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
Calsina, B., Piñeiro-Yáñez, E., Martínez‐Montes, Á. M., Caleiras, E. J., Fernández-Sanromán, Á., Monteagudo, M., Torres‐Pérez, R., Torre, C. F., Pulgarín-Alfaro, M., Gil, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36769-6 · Cited by 103
Telomeres and Age-Related Diseases
Gruber, H., Semeraro, M. D., Renner, W., & Herrmann, M. (2021) · Biomedicines · doi:10.3390/biomedicines9101335 · Cited by 102
Telomeres, aging, and cancer: the big picture
Lansdorp, P. M. (2022) · Blood · doi:10.1182/blood.2021014299 · Cited by 96
Nakao, T., Bick, A. G., Taub, M. A., Zekavat, S. M., Uddin, M. M., Niroula, A., Carty, C. L., Lane, J., Honigberg, M. C., Weinstock, J. S., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl6579 · Cited by 91
Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
Luo, Z., Wang, W., Li, F., Songyang, Z., Feng, X., Xin, C., Dai, Z., & Xiong, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1035-x · Cited by 92
Telomerase in Cancer: Function, Regulation, and Clinical Translation
Robinson, N. J., & Schiemann, W. P. (2022) · Cancers · doi:10.3390/cancers14030808 · Cited by 105
G-quadruplex in cancer biology and drug discovery
Nakanishi, C., & Seimiya, H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.178 · Cited by 102
From “Cellular” RNA to “Smart” RNA: Multiple Roles of RNA in Genome Stability and Beyond
Michelini, F., Jalihal, A. P., Francia, S., Meers, C., Neeb, Z. T., Rossiello, F., Gioia, U., Aguado, J., Jones-Weinert, C., Luke, B., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00487 · Cited by 85
Wang, H., Gong, P., Chen, T., Gao, S., Wu, Z., Wang, X., Li, J., Marjani, S. L., Costa, J. C., Weissman, S. M., et al. (2021) · Advanced Science · doi:10.1002/advs.202004320 · Cited by 88
Farmery, J. H. R., Smith, M. L., Diseases, N. B. R., Huissoon, A. P., Furnell, A., Mead, A. J., Levine, A. P., Manzur, A. Y., Thrasher, A. J., Greenhalgh, A. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-14403-y · Cited by 86
Qin, G., Mallik, S., Mitra, R., Li, A., Jia, P., Eischen, C. M., & Zhao, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-57834-w · Cited by 86
Sze, K. M., Ho, D. W., Chiu, Y., Tsui, Y., Chan, L., Lee, J. M., Chok, K., Chan, A. C. Y., Tang, C. N., Tang, V. W., et al. (2020) · Hepatology · doi:10.1002/hep.31231 · Cited by 85
The Radiation-Induced Bystander Effect (RIBE) and its Connections with the Hallmarks of Cancer
Heeran, A. B., Berrigan, H. P., & O'Sullivan, J. N. (2019) · Radiation Research · doi:10.1667/rr15489.1 · Cited by 84
Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential
Fernandes, S. G., Dsouza, R., Pandya, G., Kirtonia, A., Tergaonkar, V., Lee, S. Y., Garg, M., & Khattar, E. (2020) · Cancers · doi:10.3390/cancers12071901 · Cited by 80
Noureen, N., Wu, S., Lv, Y., Yang, J., Yung, W. K. A., Gelfond, J., Wang, X., Koul, D., Ludlow, A. T., & Zheng, S. (2021) · Nature Communications · doi:10.1038/s41467-020-20474-9 · Cited by 78
Self-citationReconstructing the molecular life history of gliomas
Barthel, F. P., Wesseling, P., & Verhaak, R. G. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1842-y · Cited by 86
Self-citationStern, J. L., Paucek, R. D., Huang, F. W., Ghandi, M., Nwumeh, R., Costello, J. C., & Cech, T. R. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.12.001 · Cited by 77
Leao, R. R. N., Lee, D., Figueiredo, A., Hermanns, T., Wild, P. J., Komosa, M., Lau, I., Mistry, M., Nunes, N. M., Price, A. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31935 · Cited by 81
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
Tay, B. Q., Wright, Q., Ladwa, R., Perry, C., Leggatt, G., Simpson, F., Wells, J. W., Panizza, B. J., Frazer, I. H., & Cruz, J. L. G. (2021) · Vaccines · doi:10.3390/vaccines9050535 · Cited by 76
Robbe, P., Ridout, K. E., Vavoulis, D. V., Dreau, H. M.-P., Kinnersley, B., Denny, N., Chubb, D., Appleby, N., Cutts, A., Cornish, A. J., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01211-y · Cited by 78
Telomere-related Markers for Cancer
Yuan, X., Dai, M., & Xu, D. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200106145340 · Cited by 77
Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level
Pillozzi, S., Bernini, A., Palchetti, I., Crociani, O., Antonuzzo, L., Campanacci, D. A., & Scoccianti, G. (2021) · Cancers · doi:10.3390/cancers13123044 · Cited by 78
Pozzo, A. R., Sisdelli, L., Cordioli, M. I. C. V., Vaisman, F., Caria, P., Mai, S., & Cerutti, J. M. (2020) · Cancers · doi:10.3390/cancers12113146 · Cited by 74
Telomerase Reverse Transcriptase (TERT) in Action: Cross-Talking with Epigenetics
Yuan, X., & Xu, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133338 · Cited by 75
Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery
Zhao, K., Liu, A., & Xia, Y. (2020) · The Innovation · doi:10.1016/j.xinn.2020.100034 · Cited by 71
Telomeres and Cancer: Resolving the Paradox
Nassour, J., Schmidt, T. T., & Karlseder, J. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050420-023410 · Cited by 70
Orzan, F., Bacco, F. D., Lazzarini, E., Crisafulli, G., Gasparini, A., Dipasquale, A., Barault, L., Macagno, M., Persico, P., Pessina, F., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2903 · Cited by 65
TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas
Tanaka, A., Matsuse, M., Saenko, V., Nakao, T., Yamanouchi, K., Sakimura, C., Yano, H., Nishihara, E., Hirokawa, M., Suzuki, K., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0695 · Cited by 67
Hiltbrunner, S., Cords, L., Kasser, S., Freiberger, S. N., Kreutzer, S., Toussaint, N. C., Grob, L., Opitz, I., Messerli, M., Zoche, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40745-5 · Cited by 78
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors
Sengupta, S., Sobo, M., Lee, K., Kumar, S. S., White, A. R., Mender, I., Fuller, C. E., Chow, L. M. L., Fouladi, M., Shay, J. W., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0792 · Cited by 61
TERT promoter mutations and telomeres during tumorigenesis
Lorbeer, F. K., & Hockemeyer, D. F. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.02.001 · Cited by 65
Takahashi, M., Miki, S., Fujimoto, K., Fukuoka, K., Matsushita, Y., Maida, Y., Yasukawa, M., Hayashi, M., Shinkyo, R., Kikuchi, K., et al. (2019) · Cancer Science · doi:10.1111/cas.14067 · Cited by 62
ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity
Lovejoy, C. A., Takai, K., Huh, M. S., Picketts, D. J., & de Lange, T. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000594 · Cited by 64
Telomerase: Key regulator of inflammation and cancer
Wu, L., Fidan, K., Um, J., & Ahn, K. S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104726 · Cited by 62
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
George, S. L., Parmar, V. S., Lorenzi, F., Marshall, L. V., Jamin, Y., Poon, E., Angelini, P., & Chesler, L. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01582-2 · Cited by 62
Telomeres and Telomerase in the Development of Liver Cancer
der Stroth, L. I., Tharehalli, U., Güneş, Ç., & Lechel, A. (2020) · Cancers · doi:10.3390/cancers12082048 · Cited by 66
TERT structural rearrangements in metastatic pheochromocytomas
Dwight, T., Flynn, A., Amarasinghe, K. C., Benn, D. E., Lupat, R., Li, J., Cameron, D., Hogg, A., Balachander, S., Candiloro, I. L. M., et al. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0306 · Cited by 61
TelNet - a database for human and yeast genes involved in telomere maintenance
Braun, D. M., Chung, I., Kepper, N., Deeg, K. I., & Rippe, K. (2018) · BMC Genetics · doi:10.1186/s12863-018-0617-8 · Cited by 60
Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof
Claude, E., & Decottignies, A. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.01.002 · Cited by 60
G-quadruplexes mark alternative lengthening of telomeres
Yang, S. Y. C., Chang, E. Y., Lim, J., Kwan, H., Monchaud, D., Yip, S. S. F., Stirling, P. C., & Wong, J. M. Y. (2021) · NAR Cancer · doi:10.1093/narcan/zcab031 · Cited by 61
Ko, E., Seo, H., & Jung, G. (2017) · Hepatology · doi:10.1002/hep.29604 · Cited by 60
TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends
Yuan, X., Dai, M., & Xu, D. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.003 · Cited by 59
Genetic bases of pheochromocytoma and paraganglioma
Cascón, A., Calsina, B., Monteagudo, M., Mellid, S., Díaz‐Talavera, A., Currás-Freixes, M., & Robledo, M. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0167 · Cited by 65
Multiple cancer pathways regulate telomere protection
Bejarano, L., Bosso, G., Louzame, J., Serrano, R., Gómez‐Casero, E., Martinez-Torrecuadrada, J. L., Martı́nez, S., Blanco‐Aparicio, C., Pastor, J., & Blasco, M. A. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910292 · Cited by 56
TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer
Agarwal, N., Rinaldetti, S. L., Cheikh, B. B., Zhou, Q., Hass, E. P., Jones, R. T., Joshi, M., LaBarbera, D. V., Knott, S., Cech, T. R., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102423118 · Cited by 58
Role of telomere length in human carcinogenesis (Review)
Tsatsakis, A. M., Oikonomopoulou, T., Νikolouzakis, Τ. Κ., Vakonaki, E., Tzatzarakis, M. N., Flamourakis, M., Renieri, E. A., Fragkiadaki, P., Iliaki, E., Bachlitzanaki, M., et al. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5526 · Cited by 65
Lu, H., Lyu, Y., Tran, T. M. L., Lan, J., Xie, Y., Yang, Y., Murugan, N. L., Wang, Y. J., & Semenza, G. L. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109757 · Cited by 54
Mechanisms that drive telomere maintenance and recombination in human cancers
Sobinoff, A. P., & Pickett, H. A. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.02.006 · Cited by 57
Nersisyan, L., Hopp, L., Loeffler‐Wirth, H., Galle, J., Loeffler, M., Arakelyan, A., & Binder, H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01172 · Cited by 55
The Solo Play of TERT Promoter Mutations
Hafezi, F., & Perez-Bercoff, D. (2020) · Cells · doi:10.3390/cells9030749 · Cited by 54
Metadata
- Authors
- Barthel, F. P., Wei, W., Tang, M., Martinez-Ledesma, E., Hu, X., Amin, S. B., Akdemir, K. C., Seth, S., Song, X., Wang, Q., Lichtenberg, T., Hu, J., Zhang, J., Zheng, S., & Verhaak, R. G. W.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Nationwide Children's Hospital (US)
- Corresponding author
- Zheng, Siyuan
- Verhaak, Roel G W
- ORCID
- Venue
- Nature Genetics
- Published
- 2017-01-30
- Volume
- 49
- Issue
- 3
- Pages
- 349-357
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC5571729
- OpenAlex
- W2581179619
- Cited by
- 614
- References
- 72
- Citations by year
- 2026: 23 · 2025: 58 · 2024: 72 · 2023: 85 · 2022: 96 · 2021: 92 · 2020: 80 · 2019: 45 · 2018: 41 · 2017: 22
- FWCI
- 38.05
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- PubMed Central (acceptedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Cancer Prevention and Research Institute of Texas (R140606)
- McGill University
- Broad Institute
- National Institutes of Health
- University of Texas MD Anderson Cancer Center (P30CA 16672)
- National Cancer Institute (R01CA190121, P01CA085878, U24CA143883, P30CA016672, P50CA127001, P30CA034196)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- telomere length, telomere maintenance, telomerase reverse transcriptase, TERT mutation, alternative lengthening of telomeres, ATRX, DAXX, Terra, TP53 mutation, RB1 mutation, sarcoma, glioma, cancer genomics
- MeSH terms
- Glioma, Humans, Neoplasms, Promoter Regions, Genetic, Sarcoma, Tumor Suppressor Protein p53, Telomere, Point Mutation, Telomerase, DNA Methylation, Ubiquitin-Protein Ligases, Retinoblastoma Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
